Login
LENSAR, Inc. logo

LENSAR, Inc.

lensar.com

What Do They Do?

Sells laser systems for cataract surgery and corneal astigmatism treatment to eye surgeons, hospitals and outpatient surgery centers.

How Do They Make Money?

Eye-care providers and distributors buy laser systems, patient interface kits and procedure licenses; most customers prepay or pay within 30 days. Direct system sales follow installation and training, distributor system sales are made at shipment, while lease and extended-warranty revenue is earned over the agreement term.

revenue
SegmentShareRevenue
Product
Sold outright

89%
FY2022: 88%
Service
Recurring

11%
FY2022: 12%

Who Are Their Customers?

In the United States, LENSAR sells directly to ambulatory surgery centers, hospitals and physicians; in Europe, Asia and other targeted international markets, third-party distributors market and sell the systems.

Customers above 10% of revenue, FY2025
of revenue from one customer
FY2024: 14% from one customer

Do Revenues Turn Into Profits?

No. It lost $34.3M in FY2025.

Operating income, FY2025
−42% of revenue
▼ −130% (Loss) vs FY2024 (−$10.7M, −20%)
Net income, FY2025
−59% of revenue
▼ −9% (Loss) vs FY2024 (−$31.4M, −59%)
Free cash flow, FY2025
−26% of revenue
▼ −513% (Loss) vs FY2024 (−$2.4M, −5%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▼ −1%
vs $14.3M in Q3 FY2025
Net income
▼ −27% (Loss)
vs −$3.7M in Q3 FY2025
Product share of product and service revenue vs 89.1% in Q3 FY2025
  • May 25, 2026 Michael Rossi appointed interim CFO Rossi also became the company's principal financial officer.
  • Apr 10, 2026 CFO Thomas Staab announces resignation He cited other professional opportunities; the company began a search for a new CFO.

Growing. Revenue grew 70% in 4 years, from $34.5M in FY2021 to $58.4M in FY2025, about 14% a year.

ALLY availability The older report described an initial launch and planned additional country applications; the latest says ALLY is available to surgeons in the United States and Europe and has clearances in additional countries.

Revenue over time
Product Service
$100M$50M$0

Who Do They Compete With?

Competes with Alcon, Bausch + Lomb, Carl Zeiss, AMO, Ziemer Ophthalmic Systems, and KERANOVA

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support